ASX: RCE

$0.0

ASX: RCE

$0.0

ASX: RCE

$0.0

The Australian – Research Special Report 2020

Posted on by officialtpss
alt="Recce Pharmaceuticals abstract"

The Australian – Research Special Report 2020

A revolutionary approach to medicine: synthetic anti-Infectives Anti-infectives are used as our frontline treatment for everyday and life threatening bacteria and viral infections…

Quick Links

About Us

Recce Pharmaceuticals Ltd (ASX:RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.

Stay up to date

Receive news and information direct to your inbox.
Twitter Linkedin-in Youtube
© 2023 Recce Pharmaceuticals